Simplify Asset Management Inc.
Position in SABS — SAB Biotherapeutics, Inc.
CIK 1846368
Las Vegas, NV
Position in SABS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$408,911
-$308,179 QoQ
Shares Held
104,849
-44.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#37
of 86 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Simplify Asset Management Inc. holds $92,744,448 across 25 Biotechnology names. SABS ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
68,560 | $16,520,903 | |
| 2 | BHVN |
Biohaven Ltd.
|
1,040,255 | $15,478,994 | |
| 3 | BNTC |
Benitec Biopharma Inc.
|
1,005,557 | $13,454,352 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
1,432,105 | $9,351,645 | |
| 5 | EYPT |
EyePoint, Inc.
|
400,044 | $5,720,629 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,456 | $5,193,808 | |
| 7 | MIST |
Milestone Pharmaceuticals Inc.
|
3,349,379 | $4,488,167 | |
| 8 | PHAT |
Phathom Pharmaceuticals, Inc.
|
249,267 | $2,704,546 |
All Filings in SABS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,911 | 104,849 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $717,090 | 187,230 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $778,768 | 208,227 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||